Telix Pharmaceuticals Ltd (TLPPF) SEC Filings — 2025

Filings

• Telix Pharma Updates China Study, FDA Resubmissions — 6-K · Dec 22, 2025
• Telix Pharmaceuticals Files ProstACT Global Study Update — 6-K · Dec 17, 2025
• Telix Pharmaceuticals Ltd 6-K Filing — 6-K · Dec 8, 2025
• Telix Pharmaceuticals Upgrades FY25 Guidance on Strong Q3 — 6-K · Oct 14, 2025
• Telix Pharmaceuticals' Goz نتix Gets CMS Pass-Through Status — 6-K · Sep 23, 2025
• Telix Pharmaceuticals and FDA Agree on Pixclara NDA Resubmission — 6-K · Sep 9, 2025
• Telix Pharmaceuticals Files NDA for TLX250-CDx with FDA — 6-K · Aug 28, 2025
• Telix Pharmaceuticals Ltd Files H1 2025 Results — 6-K · Aug 21, 2025
• Telix Pharmaceuticals Reports $240M Q2 Revenue, Up 63% YoY — 6-K · Jul 22, 2025
• Telix Pharmaceuticals' Gozellix Gets Permanent US Reimbursement Code — 6-K · Jul 9, 2025
• Telix Pharmaceuticals Files Investor Day Presentation — 6-K · Jun 11, 2025
• Telix Pharmaceuticals Ltd Files AGM Results — 6-K · May 21, 2025
• Telix Pharmaceuticals Provides Regulatory Update on TLX101-CDx — 6-K · Apr 29, 2025
• Telix Pharmaceuticals Reports $186M Q1 Revenue, Up 62% — 6-K · Apr 22, 2025
• Telix Pharmaceuticals TLX101 Shows Promising Glioma Efficacy — 6-K · Apr 17, 2025
• Telix Pharmaceuticals Responds to US Government Actions — 6-K · Apr 8, 2025
• Telix Pharmaceuticals Appoints Anne Whitaker as Director — 6-K · Apr 4, 2025
• FDA Approves Telix Pharmaceuticals' Prostate Cancer Agent — 6-K · Mar 21, 2025
• Telix Pharmaceuticals' Illuccix Approved in Brazil — 6-K · Mar 18, 2025
• Telix Pharmaceuticals Completes Theranostic Acquisition — 6-K · Mar 12, 2025
• Telix CEO to Sell Shares — 6-K · Feb 27, 2025
• FDA Grants Priority Review for Telix's Zircaix — 6-K · Feb 26, 2025
• Telix Pharmaceuticals Announces Board Renewal — 6-K · Feb 25, 2025
• Telix Pharmaceuticals Changes Reporting Currency to USD — 6-K · Feb 24, 2025
• Telix Pharmaceuticals Ltd Files 2024 Annual Report — 20-F · Feb 24, 2025
• Telix Pharmaceuticals Files 2024 Annual Report & Results — 6-K · Feb 21, 2025
• Telix Pharmaceuticals' Illuccix Approved in UK — 6-K · Feb 13, 2025
• Telix Pharmaceuticals Completes Tx Assets Acquisition — 6-K · Jan 31, 2025
• Telix Pharmaceuticals Completes Acquisition of RLS (USA) Inc. — 6-K · Jan 27, 2025
• Telix Pharmaceuticals' Illucix® Gains European Approval — 6-K · Jan 17, 2025
• Telix Pharmaceuticals to Acquire Next-Gen Therapeutics Platform — 6-K · Jan 13, 2025